SC accepts govt response on compensation for J&J hip implant victims

Panel had recommended compensation of up to Rs 1.22 crore for victims

Supreme Court
A general view of the Supreme Court after the Ayodhya hearing was rescheduled to January 29. Photo: Aashish Aryan
Aashish Aryan New Delhi
Last Updated : Jan 11 2019 | 10:54 PM IST
The Supreme Court on Friday accepted the government’s response on the compensation formula it had arrived at for victims of faulty hip implants manufactured by Johnson & Johnson (J&J). The top court also asked the central government to give wide publicity to the scheme so that the victims could come and claim compensation.

Disposing off the Public Interest Litigation (PIL) filed in the case, a two-judge bench of Chief Justice Ranjan Gogoi and Justice S K Kaul considered the response filed by the Health Ministry and said that steps had been taken to provide compensation to the victims.

A PIL filed in the top court had alleged that "faulty" and "deadly" hip implants have been fitted into the bodies of 4,525 Indian patients who had undergone replacement surgeries since 2005. Though J&J requested to record in the order that disposal of the PIL would not prejudice its case going on in the Delhi High Court, top court refused to do so and closed the PIL.

Earlier on December 13 last year, the Delhi High Court had refused to hear J&J's plea challenging the government notification asking them to pay compensation to patients affected by faulty hip implants and deferred the matter to February 26, 2019. A single-judge Bench of Justice Vibhu Bakhru had then said that the company’s plea was “neither important nor urgent” and hence would not be heard immediately.

In 2017, the Centre had set up a committee led by Arun Aggarwal to look after patients’ problems caused by faulty hip implants produced and distributed by Johnson & Johnson India and DePuy Orthopaedics INC collectively. DePuy Orthopaedics Inc is a fully-owned arm of J&J.  The committee, which submitted its report in August 2018, had found J&J guilty of concealing information and said that the company should continue the compensation program till August 2025 so that all patients were duly reimbursed. It had suggested that the victims be provided compensation between Rs 3 lakh and Rs 1.22 crore.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Next Story